Skip to Main Content

Paper Details

Increased mTOR activation in idiopathic multicentric Castleman disease.
Blood
50
2020
Hodgkin lymphoma, IL-6, Idiopathic multicentric Castleman disease, Interleukin-6, JAK1/2, T cells, anti-IL-6, autoimmune lymphoproliferative syndrome, cytopenias, dysregulated cell types, hematologic disorder, iMCD, idiopathic multicentric Castleman disease, inflammatory lymphadenopathy, lymphadenopathy, lymphoproliferation, mTOR, mTORC1, multiorgan dysfunction, p4EBP1, p70S6K, pS6, patients, peripheral monocytes, sirolimus, systemic inflammation, systemic lupus erythematosus

Datasets

Release 1.2